Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envision Scientific is a research-driven medical device company based in India that specializes in the development and manufacturing of innovative cardiovascular and endovascular solutions. The company is recognized for its pioneering work in nanoparticle-based drug delivery systems, which are integrated into its flagship drug-eluting stents and balloons. Their primary product, the Abluminus sirolimus-eluting stent, utilizes a unique coating technology designed to optimize drug release and promote vessel healing. Envision Scientific maintains a strong focus on clinical research, frequently conducting large-scale trials to validate the safety and efficacy of its interventional products. The company's technologies aim to address complex vascular conditions such as coronary artery disease and peripheral arterial disease. With a presence in international markets through CE-marked products, Envision Scientific continues to advance the field of interventional cardiology through technological innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envision Scientific.